First human test: new drug EB070 enters safety trial
Knowledge-focused
Not yet recruiting
This is a first-in-human study to check if a new injectable drug called EB070 is safe for people. Researchers will give single shots of EB070 at different dose levels to 36 healthy volunteers and closely monitor them for side effects. The main goal is to understand how the body h…
Phase: PHASE1 • Sponsor: Biotech Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC